ACXP

Acurx Pharmaceuticals LLC

NASDAQ: ACXP · HEALTHCARE · BIOTECHNOLOGY

$1.46

-0.68% today

Updated 2026-08-06

Market cap

$6.15M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.79

Dividend yield

—

52W range

$1 – $8

Volume

0.1M

Market cap

$6.15M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.79

Dividend yield

—

52W range

$1 – $8

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →209 stocks currently score above 75

Price targets

Analyst target

$17.00

+1064.38%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-1.41M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-12.09M	$-14.58M	$-14.10M	$-7.97M	$-1.68M
EPS	—	—	—	—	$-3.79
Free cash flow	$-7.54M	$-9.80M	$-10.38M	$-6.79B	$-1.41M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ACXP	$6.15M	26	4.3	3.0	5.0	6.0	—	Avoid
LLY	$1.02T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$614.36B	57	4.7	8.5	3.3	6.0	-84.82%	Buy
ABBV	$430.82B	73	6.7	8.5	4.7	5.0	-63.15%	Strong Buy
UNH	$370.11B	62	7.3	5.5	4.0	6.0	-28.08%	Buy
MRK	$316.14B	50	3.3	8.0	2.7	5.0	-57.98%	Hold

Smart narrative

Acurx Pharmaceuticals LLC trades at $1.46. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score.

Frequently asked questions

What is Acurx Pharmaceuticals LLC's stock price?

Acurx Pharmaceuticals LLC (ACXP) trades at $1.46.

Is Acurx Pharmaceuticals LLC overvalued?

Acurx Pharmaceuticals LLC carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Acurx Pharmaceuticals LLC (ACXP)?

The 12-month analyst consensus target is $17.00, about 1064.4% above the current $1.46. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-106.92%

Beta-2.03

50D MA$1.61

200D MA$2.95

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ACXP vs LLY →ACXP vs JNJ →ACXP vs ABBV →Stock screener →